Half of cancer patients face care hurdles

November 29, 2022 02:03 PM AEDT | By AAPNEWS
Follow us on Google News:
Image source: AAPNEWS

More than half of Australian cancer patients experience systemic barriers to accessing the care they need, a new report has found.

The report, Addressing The Hidden Burdens of Cancer Care, said the majority of those surveyed noted complexities in navigating cancer screening, diagnosis and treatment, as well as the difficulties of managing life around their care.

The nearly 600 Australian patients surveyed said the most common barrier to care is around getting the right information at the right time to make informed decisions.

It is estimated that 162,000 new cancer cases will be diagnosed this year and an estimated 50,000 people will die. 

Conducted by Australia's largest dedicated cancer care provider Icon Group, the report found 28 per cent said deciding on the right treatment pathway was one of the hardest parts of their experience.

One in five said finding the right healthcare professionals was the most challenging part about living with cancer.

And one in five also said the lack of integration and communication of information between different healthcare providers was distressing, while 18 per cent said a lack of reliable and timely information was a barrier.

Icon Group chief executive Mark Middleton said patients demanded "a system that talks to each other and provides a connected service that involves them ... every step of the way".

Cure Brain Cancer Foundation head Lance Kawaguchi said when it comes to care options, knowledge for patients is key.

"We can offer the best cancer care in the world but if people don't know it is available to them or feel lost in the system, they can't benefit from it," he said.

In collaboration with advocacy groups, Icon has committed to short-term solutions including setting up local and regional forums to help get quality information and support to the patient at the right time.

"By coming together, we can focus our collective power to remove systemic barriers and innovate the cancer experience on a scale not seen before," Mr Middleton said. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK